University of Georgia Dewey Prescription for Success Business Ethics Discussion I need a 4 paragraph post for each Learning Activity. The sources I attach

University of Georgia Dewey Prescription for Success Business Ethics Discussion I need a 4 paragraph post for each Learning Activity. The sources I attach are the only ones you can use for citations. I need at least three of the sources for each post. APA Format. For in-text citations it should be, (Author, Publication Year, page number). If there is no page number just exclude it. Make sure that you really show an understanding of the concepts in each learning activity. Also, see attached for the instructor’s notes for this week. It may give you an idea of what is expected.

SOURCES TO BE USED:
Theme 1: Pharmaceutical Industry

The Importance of Patents: It Pays to Know Patent Rules
Why Patent Protection In The Drug Industry Is Out Of Control
Is a Patent a Monopoly? —Antitrust Considerations
First-To-File Patent Law Is Imminent, But What Will It Mean?

Theme 2: Products of Liability

Off-label Use: The Fine Line Between Illegal Promotion and Useful Information
The Danger Of Loosely Regulated Supplements
Unregulated supplements send thousands to hospital each year
The ethics of global clinical trials In developing countries, participation in clinical trials is sometimes the only way to access medical treatment. What should be done to avoid exploitation of disad
IRB Considerations for Investigator – Initiated Research
Supreme Court lets pay-to-delay ruling against pharma stand
Appendix K Antibiotics In Animal Feeds
Ethical dimensions of the prescription opioid abuse crisis
The War on Opioids: An Ethical Perspective

Theme 3: Whistleblowing

What’s Ethical About Whistleblowing?
5 famous whistleblowers who risked everything
Our Successful Whistleblower Cases

Learning Activity #1

Dewey’s Prescription for Success

Dewey Cheatham is the new Vice President of Marketing for a large online search engine company, Pottstown Innovative Enterprises (AKA, PIE). Dewey has been doing some research into how he can increase the Company’s revenues and thereby really impress the Company brass. During his research he came across an article about Brazilian pharmacies looking for an advertising vehicle to tap into the U.S. consumer market. Further research reveals that this could be a billion dollar venture and if PIE plays its cards right, it could make a substantial amount of money given its extensive advertising network. Dewey is super ecstatic about the possibilities and is salivating over what this could mean for his career with PIE.

Before Dewey decides to go ahead with this, he consults with his legal department. The legal department tells Dewey the following:

1. The shipment of prescription drugs from pharmacies outside the United States to customers in the United States may violate the Federal Food, Drug and Cosmetic Act and in the case of controlled prescription drugs, the Controlled Substances Act.

2. The FDA cannot ensure the safety and effectiveness of foreign prescription drugs that are not FDA-approved.

3. Imported drugs typically do not meet FDA’s labeling requirements and may not have been manufactured, stored and distributed under proper conditions; and may not have been dispensed in accordance with a valid prescription.

4. The government has historically been very lax in enforcing the laws in this area and legally there are a few gray areas; therefore, the risk of any prosecution may not be significant.

After the consultation with Legal, Dewey is confused as to what his decision should be. If you were advising Dewey on the ethical implications presented by this case, what would you say to him? Specifically, identify and discuss: the ethical dilemma Dewey faces (be certain to provide Dewey with a resolution of his ethical dilemma) and the ethical issues associated with the ethical dilemma. Identify and discuss the relevant stakeholders for the Dewey and his company.

Learning Activity # 2

Whistle-blowing: Harder Than It Looks?

R.U. Kidding, the comptroller for Rocket Man Enterprises, a government defense contractor, has a delicate ethical issue on his hands. In the course of his employment, Kidding has uncovered evidence that seems to indicate that Rocket Man has been overbilling the government for a weapons system project. Under its contract with the government, Rocket Man was supposed to calculate its hourly rate with a formula dividing charges between the more expensive work done directly in their offices and the less costly hourly labor performed by subcontractors. What Rocket Man did was simple: they billed subcontractor work at the higher in-house rate.

R.U. Kidding, realizing that the weapons system project is the lifeblood of Rocket Man, is at a loss as to what he should do with the information he has uncovered. On the one hand he feels he has a duty to bring this wrongdoing to light. After all, he reasons, there is the greater public interest and common good to consider. On the other hand, the project is so critical to the financial future of the Company that the disclosure of wrongdoing could be devastating for the Company and its employees, many of whom are R.U.’s colleagues and friends. If you were in R.U.’s shoes, what would you do and why? What specifically are the ethical dilemma and the related ethical issue for R.U.?. This week we continue our ethics journey with a focus on three
themes, patents, products of liability, and whistle-blowing. In
considering the themes, still keep in mind the importance of ethical
culture created by the organization and the internal ethical compass
we discussed in week one. The consideration of a company’s ethical
climate and culture as well as your internal compass will impact how you
feel about the ethical themes for this week.
The question of ethics and patents presents some interesting
dynamics. Given our limited time, I do not expect that we will become
experts in the area of patents, a topic which has perplexed
practitioners and scholars alike. For our purposes, focus on the
broader context that patents are a recognized system whereby one
receives exclusive rights to the profits from a process or product for
a certain number of years. During such time, the holder of the patent
is protected against the exploitation for profit of the product or
process by others. The system raises at least two ethical
considerations which I would like you to give some thought to. First,
what if the holder of the patent simply sits on the process or product
and makes no attempt to improve the process or profit. Is it fair that
such a holder can preclude others from improving the process or
product? The second ethical question arises out of a resource for the
week, “First-To-File Patent Law Is Imminent, But What Will It Mean?”.
What do you think of the fairness of a first to file system? What if
the originator simply lacked the resources to pursue the patent?
Our second theme deals with products of liability, and more
specifically those concerning pharmaceuticals. There are several
resources on the subject of supplements, and as you review these,
think about whether this is an area that the government should do
more from a regulatory standpoint, or whether the makers can be
trusted to their own devices to be ethical. Similar to the question of
intervention versus self-policing, is the ethical question of whether
manufacturers or makers should consider the overall well-being of
society when they are deciding what products to produce. There is an
interesting article this week on opioids, “The War on Opioids: An
Ethical Perspective”. Given the societal problems associated with the
abuse of opioids, should the companies that manufacture such products
do more to address the abuses, or should they shrug their shoulders
and say that it is the government’s responsibility? To a large extent
how a company responds to such a question reflects mightily on the
ethical culture we have discussed before. In Learning Activity # 1, we
focus on a number of the questions regarding the introduction of
medical products into the marketplace through the actions of the
fictitious company, Pottstown Innovative Enterprises (AKA PIE).
Our third theme, whistle blowing, is a fascinating subject with a myriad
of ethical questions and issues. One of the more highly publicized cases
of recent note was the case of Edward Snowden and the National
Security Agency (NSA). There are some who argue he is not a whistle
blower at all but rather a criminal, while others view him as the classic
whistle-blower—one who sees wrongdoing and reports it. Underlying
the notion of whistle-blowing is the question of whether one has a duty
of loyalty to one’s employer or to the public at large. As suggested in
your material, the decision to become a whistle-blowing is not an easy
one because it generally results in dramatic and often catastrophic
changes in one’s life. Whistle-blowers are often among other things,
ostracized at work, sometimes fired or demoted, and the subject of
unwanted and vicious coverage in the news. Learning Activity # 2,
explores some of the issues associated with whistle-blowing. As you
consider the topic, think about your own internal ethical compass and
what you might do if such a situation presented itself.

Purchase answer to see full
attachment